McMaster, William C.; Sale, Katherine; Andersson, Gunnar B. J.; Bostrom, Mathias P. G.; Gebhardt, Mark C.; Trippel, Stephen B.; Clark, David C.
December 2006
Journal of Bone & Joint Surgery, American Volume;Dec2006, Vol. 88-A Issue 12, p2765
Academic Journal
The article discusses how privacy and the confidentiality of health information should be protected in the medical research environment. Under the Health Insurance Portability and Accountability Act (HIPAA), researchers are required to observe compliance requirements for conducting clinical research. The privacy rule as envisaged by the HIPAA is designed to prevent unauthorized access to protected health information.


Related Articles

  • Biological Sex Analysis in Clinical Research. Woosley, Raymond L.; Anthony, Marietta; Peck, Carl C. // Journal of Women's Health & Gender-Based Medicine;Nov2000, Vol. 9 Issue 9, p933 

    This article presents an argument pertaining to sex analysis in clinical research. In 1993, the U.S. Congress enacted legislation that required researchers funded by the National Institutes of Health (NIH) to include appropriate numbers of women and minorities in clinical research and, when...

  • Biotech challenge. Kidman, Angus // Bulletin with Newsweek;8/13/2002, Vol. 120 Issue 6337, p58 

    Reports the demand of the U.S. government for the compliance on the standards protecting privacy in clinical trials. Information on the regulation; Effects of the regulation on local providers; Requirements on audit trails and password security.

  • Are HIPAA privacy changes coming?  // Healthcare Risk Management;Feb2008, Vol. 30 Issue 2, Special section p1 

    The article discusses the impact of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) privacy provisions in the U.S. According to an epidemiologist Roberta Ness at the University of Pittsburgh, the vast majority of clinical scientist said the HIPAA has had a negative...

  • India's next challenge: Rebooting recruitment. Bhatt, Arun // Perspectives in Clinical Research;Jul-Sep2014, Vol. 5 Issue 3, p93 

    The article presents the author's views on recruitment in the clinical trial industry in India. According to report, only 30% of patients in India are likely give consent for clinical trial. The author states that while regulatory scenario improves in India, the industry should refocus on...

  • European researchers up in arms over new clinical trials edict. Bosch, Xavier // Nature Medicine;Nov2003, Vol. 9 Issue 11, p1336 

    Reports that European researchers are appealing to their respective national governments as of November 1, 2003 to reject an edict which intends to standardize and simplify rules governing clinical trials. Reasons for opposition of the reform of rules governing clinical trials by researchers;...

  • "Policy Push: Hits and Misses!". KOUL, RAHUL // BioSpectrum;Jan2014, Vol. 12 Issue 1, p27 

    The article looks at the positive and negative decisions made by the lawmakers with respect to the bioscience industry in India in 2013. Topics discussed include the healthcare research, open source drug discovery, and biological attacks roadmap. Also mentioned are the negative policy for the...

  • New clinical trials policy at FDA. Vastag, Brian // Nature Biotechnology;Sep2006, Vol. 24 Issue 9, p1043 

    The article reports on the implementation of clinical trials among drug manufacturers in the U.S. The legislation is enforced by the country's Food and Drug Administration to minimize the risk of manipulating drug doses. Adaptive trials are believed to bring forth quality medicines and ensure...

  • Clinical research into the ICU: clouds at the horizon, once again. Matei, Mihaela; Kompanje, Erwin; Maas, Andrew; Menon, David; Lemaire, Francois // Intensive Care Medicine;Aug2013, Vol. 39 Issue 8, p1479 

    The authors discuss the proposed regulation by the European (EU) Commission in Brussels, Belgium aimed at giving the same legislation to all EU Member States for clinical trials on medicines. They emphasize the implementation of the legal form of regulation across the EU with no adaptation to...

  • A step backwards: New rules extend EU clinical timelines. Moran, Nuala // BioWorld Today;12/24/2013, Vol. 24 Issue 246, p1 

    The article focuses on the new rules on clinical trials in Europe. It states that the long-awaited rules in clinical trials will fail to present on the main goal of speeding up approvals, following a political compromise resulted the suggested timelines for empowering trials to be extended. It...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics